CE mark
Geneseeq Nabs CE Marks for Residual Disease and Cancer Early Detection Tests
The MRD assay uses deep sequencing to detect cancer mutations in blood post-surgery and the early detection test involves multiomic analysis of cell-free DNA.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit
The company's PanCanSeek test uses whole-genome sequencing to analyze bone marrow samples from leukemia patients, replacing a variety of more targeted technologies.
SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test
The company's SeekInCure pan-cancer assay detects minimal residual disease in patient blood samples and has been validated in hepatocellular carcinoma.
Cepheid Nabs CE Mark for Group B Strep Test
The PCR-based Xpert Xpress GBS test can help screen pregnant women for Streptococcus infections that can lead to early-onset neonatal sepsis.